Navigation Links
Proscia Hosts Webinar on Digital Pathology Adoption Best Practices
Date:10/11/2017

Proscia Inc., a data solutions provider for digital pathology, announced today it will be hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing Director of Advanced Pathology Associates, on digital pathology adoption best practices and how Proscia improves lab economics and realizes an increase in diagnostic confidence.*

A live webcast from Dr. Cacciabeve’s lab will take place on Thursday, October 19, 2017 at 4:00 p.m. EDT. To join the liver webinar event, please register via Proscia’s website: https://proscia.com/webinar.

“Proscia’s new clinical solutions give us the flexibility to adopt digital pathology in phases and set us on a course to incorporate Proscia’s AI-based computational pathology applications,” said Dr. Nicolas Cacciabeve, Managing Director of Advanced Pathology Associates, a 15-pathologist independent practice providing service to seven hospitals and an anatomic pathology reference laboratory in the Rockville, Maryland area. “In this webinar, I will walk through how our lab is being transformed by utilizing Proscia’s software and share best practices for adopting digital pathology based on your lab’s needs.”

During the webinar you will hear a Proscia customer speak about adopting digital pathology and how it’s helping transform their lab. Additionally you can:

  • Learn how Proscia’s modular software can help you adopt digital pathology at your own pace.
  • See some of the powerful clinical applications of Proscia’s platform, including consultation and digital immunohistochemistry (IHC).
  • Explore how Proscia drives precision medicine and computational pathology in your lab with machine learning and artificial intelligence (AI) techniques.

“With the recent FDA approval of the first WSI scanner for primary diagnosis, digital pathology adoption is happening at an accelerated pace,” said David West, chief executive officer of Proscia. “Labs are recognizing the broad benefits of going digital, creating exciting opportunities for new revenue streams and broadening the impact that pathology has on cancer diagnosis and research. Proscia’s award-winning software is uniquely positioned in this transition to deliver applications for clinical use-cases and set the stage for AI-based computational pathology.”

*Proscia software is not intended for primary diagnostic use.

About Proscia
Proscia was founded in 2014 by a team out of Johns Hopkins, the Moffitt Cancer Center, and the University of Pittsburgh to improve clinical outcomes and accelerate the discovery of breakthrough advancements in the fight against cancer. Using modern computing technologies that unlock hidden data not visible to the human eye and turning that data into valuable insights in the fight against cancer, the company is dedicated to improving the efficiency, speed and quality of pathology diagnostics and research. To learn more, please visit http://www.proscia.com.

Read the full story at http://www.prweb.com/releases/2017/10/prweb14792950.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Proscia Announces Massive Dataset Migration Service to Accelerate Transfer of Large-Scale Digital Pathology Image Data to the Cloud
2. Proscia Partners with Samsung Medical Center to Research Predictive Medicine in Cancer Diagnosis and Treatment
3. Proscia and Huron Digital Pathology Partner to Provide Seamlessly Integrated Digital Pathology Scanner-Software Solution
4. Proscia Takes on Subjectivity in Pathology Through AI Innovation
5. Frost & Sullivan Identifies Proscia as a Game-changing Company in Cloud-based Digital Pathology
6. Proscia’s Artificial Intelligence to Transform Pathology Labs and Drive Their Digital Evolution
7. Proscia Takes Aim at Cancer with Artificial Intelligence and Digital Pathology Software
8. Proscia Provides Agilent Technologies with Digital Pathology Platform for Interactive Version of the Dako Atlas of Stains
9. Proscia and Huron Digital Pathology Host Pre-Conference Workshop on Best-in-Class Strategies for Digital Pathology Adoption
10. Proscia to Transform the Clinical Use of Digital Pathology in Commercial and Hospital Labs
11. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and cooking ... initiative announced today. The bold new look is part of a transformation to ... into a significant growth period. , It will also expand its service offering from ...
(Date:10/10/2017)... DALLAS , Oct. 10, 2017 International research firm ... IoT Strategy, will speak at the TMA 2017 Annual Meeting , ... key trends in the residential home security market and how smart safety ... ... "The ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):